Invitrogen™ VSIG2 Polyclonal Antibody

Rabbit Polyclonal Antibody

Supplier:  Invitrogen™ PA5100783

Catalog No. PIPA5100783

Description

Antibody detects endogenous levels of total VSIG2.

CTXL, a cortical thymocyte marker, is a member of the immunoglobulin (Ig) superfamily and has features of both antigen specific receptors and adhesion molecules. This single pass, type I protein contains a signal peptide, an extracellular V type Ig like domain followed by a C2 type Ig like domain and a cytoplasmic tail. Expression levels of CTXL are high in the stomach, colon, prostate, trachea, and thyroid gland, with lower levels observed in bladder and lung tissues. CTXL is not expressed in the thymus. CTXL is developmentally regulated and may be involved in thymocyte selection. It localizes to junctional complexes between endothelial and epithelial cells and may play a role in cell-cell adhesion and transmigration of leukocytes.

Specifications

• Antigen: VSIG2
• Classification: Polyclonal
• Conjugate: Unconjugated
• Gene: VSIG2
• Gene Alias: 1190004B15Rik; 2210413P10Rik; AU040484; cortical thymocyte receptor (X. laevis CTX) like; cortical thymocyte-like protein; CTH; CT-like protein; Ctm; CTX; CTXL; RGD1561274; UNQ2770/PRO7154; V-set and immunoglobulin domain containing 2; V-set and immunoglobulin domain-containing protein 2; VSIG2
• Host Species: Rabbit
• Purification Method: Affinity chromatography
• Regulatory Status: RUO
• Gene ID (Entrez): 23584, 300520
• Content And Storage: -20°C
• Form: Liquid

• Applications: Immunohistochemistry (Paraffin), Western Blot
• Concentration: 1 mg/mL
• Formulation: PBS with 50% glycerol and 0.02% sodium azide; pH 7.4
• Gene Accession No.: Q96IQ7
• Gene Symbols: VSIG2
• Immunogen: A synthesized peptide derived from human VSIG2(Accession Q96IQ7), corresponding to amino acid residues T131-R181.
• Quantity: 100 μL
• Primary or Secondary: Primary
• Target Species: Human, Rat
• Product Type: Antibody
• Isotype: IgG

Safety and Handling

WARNING: Cancer - www.P65Warnings.ca.gov